Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
06/1999
06/09/1999EP0920523A1 Hsv strain lacking functional icp27 and icp34.5 genes
06/09/1999EP0920510A1 GnRH-LEUKOTOXIN CHIMERAS
06/09/1999EP0920507A2 Secreted proteins and polynucleotides encoding them
06/09/1999EP0920503A2 A novel human leptin receptor gene-related protein
06/09/1999EP0920446A1 Conformationally constrained backbone cyclized somatostatin analogs
06/09/1999EP0920434A2 Bis-platinum complexes with polymethylene derivatives as ligands having antitumor activity
06/09/1999EP0920424A1 Non-peptide bombesin receptor antagonists
06/09/1999EP0920331A1 Treatment and prevention of infections, inflammations and/or tumours with lactoferrin and/or lactoferricin
06/09/1999EP0920330A1 hCG AND DERIVATIVES AS MATRIX METALLOPROTEASES INHIBITORS
06/09/1999EP0920328A1 Allogeneic histocompatibility complexes as mediators of cell destruction
06/09/1999EP0920325A2 Tetrapeptide derivatives of dolastatin as antitumor agents
06/09/1999EP0920312A1 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents
06/09/1999EP0920310A1 Use of aminothiolester derivatives in pharmaceutics
06/09/1999EP0920305A1 Identification of genes altered in multiple myeloma
06/09/1999EP0784613B1 Colchicine derivatives and the therapeutical use thereof
06/09/1999EP0775103B1 Retinoic acid x-receptor ligands
06/09/1999EP0751932B1 Vitamin-d amide derivatives
06/09/1999EP0730598B1 Hindered esters of rapamycin and their use as pharmaceuticals
06/09/1999EP0666738B1 Inhibitors of farnesyl-protein transferase
06/09/1999EP0626963B1 Vinylene-azaindole derivatives and process for their preparation
06/09/1999EP0614456B1 1alpha,24(s)-dihydroxy vitamin d2, its formation and use
06/09/1999CN1219174A Inhibitors of protein farnesyl transferase
06/09/1999CN1218833A Polypeptide with cell withering promoting activity
06/08/1999US5910574 Human trk receptors and neurotrophic factor inhibitors
06/08/1999US5910505 Leukotriene antagonists for use in the treatment or inhibition of oral squamous cell carcinoma
06/08/1999US5910491 Highly lipophilic camptothecin derivatives
06/08/1999US5910485 Lower toxicity and high effectiveness through mixture with doxorubicin (adriamycin)
06/08/1999US5910437 Ligated d-protein of formula r-l-r' where r and r' are peptides and l is linking group of thiol ester or selenol ester; for production of chirally pure chemicals and drugs; production of racemic crystals; prolonged half-life in body
06/08/1999US5910431 Polynucleotides encoding chemokine α-2
06/08/1999US5910430 Isolated nucleic acid encoding G-protein coupled receptor (HTADX50)
06/08/1999CA2242308A1 Novel compounds
06/08/1999CA2028465C Novel anthracycline glycoside derivatives and preparing method thereof
06/08/1999CA1340587C Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human mucin and with synthetic carbohydrate-carrier conjugates
06/04/1999CA2255180A1 N-(4-carbamimido-phenyl)-phenylglycinamid derivatives
06/03/1999WO1999027136A1 Decreasing cell proliferation by decreasing levels of pp5
06/03/1999WO1999027134A1 Antisense oligonucleotide modulation of human serine/threonine protein phosphatase gene expression
06/03/1999WO1999027111A1 Desaturase genes and their use
06/03/1999WO1999027103A1 Mammalian cytokine-like polypeptide-10
06/03/1999WO1999027098A2 A-33 related antigens and their pharmacological uses
06/03/1999WO1999027095A1 Human cdc10 homolog
06/03/1999WO1999027080A2 Human protein kinase and kinase inhibitors
06/03/1999WO1999026979A1 Lactalbumin production process
06/03/1999WO1999026976A1 Tnf ligand family gene
06/03/1999WO1999026961A1 Secreted proteins and polynucleotides encoding them
06/03/1999WO1999026959A1 NOVEL recJ
06/03/1999WO1999026945A1 1,3,4-THIADIAZOLES AND 1,3,4-OXADIAZOLES AS αvβ3 ANTAGONISTS
06/03/1999WO1999026943A1 Thrombin receptor antagonists
06/03/1999WO1999026939A1 Intermediates and methods useful in the semisynthesis of paclitaxel and analogs
06/03/1999WO1999026929A1 Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
06/03/1999WO1999026909A2 Alpha-hydroxy, -amino and -fluoro derivatives of beta-sulphonyl hydroxamic acids as matrix metalloproteinases inhibitors
06/03/1999WO1999026647A1 Use of heparin-binding protein for the modulation or prophylaxis of apoptosis of mammalian cells
06/03/1999WO1999026622A1 Use of fc101 as an angiogenesis inhibitor for the treatment of cancer and other angiogenic diseases
06/03/1999WO1999026611A1 Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
06/03/1999WO1999026609A2 Therapeutic treatment for chronic myeloid leukemia and acute lymphoid leukemia
06/03/1999WO1999026535A1 Reagent for tumor therapy and/or imaging
06/03/1999WO1999026463A2 Tnf ligand family gene
06/03/1999WO1999015656A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
06/03/1999WO1999014242A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
06/03/1999WO1999013871A3 Fused imidazole derivatives for improving oral bioavailability of pharmaceutical agents
06/03/1999WO1999012965A3 April- a novel protein with growth effects
06/03/1999WO1999012951A8 Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases
06/03/1999WO1999012566A9 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
06/03/1999WO1999005096A3 Urokinase inhibitors
06/03/1999CA2641217A1 Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor
06/03/1999CA2592380A1 Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor
06/03/1999CA2312000A1 Mammalian cytokine-like polypeptide-10
06/03/1999CA2311736A1 Therapeutic treatment for chronic myeloid leukemia and acute lymphoid leukemia
06/03/1999CA2311683A1 Secreted proteins and polynucleotides encoding them
06/03/1999CA2311472A1 Desaturase genes and their use
06/03/1999CA2310987A1 Tnf ligand family gene
06/03/1999CA2310841A1 Reagent for tumor therapy and/or imaging
06/03/1999CA2310750A1 Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
06/03/1999CA2310565A1 Human protein kinase and kinase inhibitors
06/03/1999CA2310540A1 Human cdc10 homolog
06/03/1999CA2310401A1 Alpha-hydroxy, -amino and -halo derivatives of beta-sulfone hydroxamates as matrix metalloproteinase inhibitors
06/03/1999CA2309888A1 Decreasing cell proliferation by decreasing levels of pp5
06/03/1999CA2309358A1 A-33 related antigens and their pharmacological uses
06/03/1999CA2309204A1 1,3,4-thiadiazoles and 1,3,4-oxadiazoles as .alpha.v.beta.3 antagonists
06/02/1999EP0919622A2 Surface expression of enzyme in gene directed prodrug therapy
06/02/1999EP0919620A2 TRAILLK-3: a member of the TNF ligand family
06/02/1999EP0919544A1 Compounds useful for treating allergic and inflammatory diseases
06/02/1999EP0919240A1 Anticancer composition
06/02/1999EP0919187A1 X-Ray imaging
06/02/1999EP0918875A1 Novel internal ribosome entry site and vector containing same
06/02/1999EP0918872A1 A method for inhibiting immunoglobulin-induced toxicity resulting from the use of immunoglobulins in therapy and in vivo diagnosis
06/02/1999EP0918871A2 Afc1 and rce1:isoprenylated caax processing enzymes
06/02/1999EP0918867A2 Substrate trapping protein tyrosine phosphatases
06/02/1999EP0918864A2 PROTEINS, IN PARTICULAR MEMBRANE PROTEINS, OF $i(HELICOBACTER PYLORI), THEIR PREPARATION AND USE
06/02/1999EP0918857A1 Human induced tumor protein
06/02/1999EP0918856A2 Two human nsp-like proteins
06/02/1999EP0918848A1 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with rna
06/02/1999EP0918795A1 Antiangiogenic drug to treat cancer, arthritis and retinopathy
06/02/1999EP0918788A1 Brca1 compositions and methods for the diagnosis and treatment of breast cancer
06/02/1999EP0918785A1 Cellular injury response element and uses thereof
06/02/1999EP0918784A1 Alkylated nucleoside-3'-phosphates, process for producing them and their use
06/02/1999EP0918776A1 Total synthesis of antitumor acylfulvenes
06/02/1999EP0918771A1 Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase
06/02/1999EP0918757A1 8-hydrocarbyl substituted benzodizocine derivatives, their preparation and their use as protein kinase c (=pkc) modulators
06/02/1999EP0918754A1 Anthranilic acid diamides derivatives, their preparation and pharmaceutical use as anti-gastrin agents
06/02/1999EP0918752A2 Dna-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents
1 ... 1964 1965 1966 1967 1968 1969 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 ... 2211